PhD student in host-pathogen interaction / drug discovery 100%

at  Universitt Basel

The Swiss Tropical and Public Health Institute (Swiss TPH) is a world-leading institute in global health with a particular focus on low- and middle-income countries. Associated with the University of Basel, Swiss TPH combines research, education and services at local, national and international level. 950 staff and students from 95 nations work at Swiss TPH focusing on climate change, environment and health, infectious and non-communicable diseases, societal and cultural context, and health systems and policies.
The Department of Medical Parasitology and Infection Biology (MPI) investigates the biology and transmission of pathogens. Findings from this research inform the development of new diagnostics, treatments, and vaccines against malaria, tuberculosis, schistosomiasis, Chagas and other neglected tropical diseases.
Within the Parasite Chemotherapy Unit of MPI, we are looking for a PhD student in host-pathogen interaction / drug discovery 100%.
We are seeking a PhD student for the research project “iPS technology to decipher leishmaniasis”. This project is funded by the Walter-Fischli-Foundation. The successful applicant will be based at the Swiss TPH and registered for a PhD degree at the University of Basel, Switzerland. The anticipated start is in Fall 2024.

YOU SHOULD HAVE THE FOLLOWING EXPERIENCE AND SKILLS:

• Master’s degree in the Life Sciences
• Skills in cell biology and molecular biology
• Strong interest in infection biology and drug discovery
• Effective communication in spoken and written English
• Ability to work independently and as part of a public-private collaborative team

Please refer the Job description for details